1-3 of 3
enoxaparin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial

Clinical Trials & Observations
Jeffrey I. Zwicker, Joanna Roopkumar, Maneka Puligandla, Benjamin L. Schlechter, Anish V. Sharda, David Peereboom, Robin Joyce, Bruno Bockorny, Donna Neuberg, Kenneth A. Bauer, Alok A. Khorana
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2254–2260.
https://doi.org/10.1182/bloodadvances.2020001804
Published: 2020
Journal Articles

The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis

Clinical Trials & Observations
Leonard Naymagon, Douglas Tremblay, Nicole Zubizarreta, Erin Moshier, Kevin Troy, Thomas Schiano, John Mascarenhas
Journal: Blood Advances
Blood Adv (2020) 4 (4): 655–666.
https://doi.org/10.1182/bloodadvances.2019001310
Published: 2020
Journal Articles

Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitors

Manu T. Kalathottukaren, A. Louise Creagh, Srinivas Abbina, Genmin Lu, Mark J. Karbarz, Anjali Pandey, Pamela B. Conley, Jayachandran N. Kizhakkedathu, Charles Haynes
Journal: Blood Advances
Blood Adv (2018) 2 (16): 2104–2114.
https://doi.org/10.1182/bloodadvances.2016003616
Published: 2018
Includes: Supplemental data